House Democrats take aim at price hikes for Valeant drugs; shares drop Staff
Posted: Sep 28, 2015 2:27 PM
(Reuters) - All 18 Democratic members of a U.S. House of Representatives committee on Monday urged their chairman to subpoena Canada's Valeant Pharmaceuticals International Inc to force it to provide documents related to "massive" price increases for two of its heart drugs.

Recommended Townhall Video